The effect of new quaternary phosphonium salts with highest alkyl substituents on the permeability of cell membranes for sodium ions in vitro

Cover Page

Cite item

Full Text

Abstract

Aim. To assess the effect of newly synthesized quaternary phosphonium salts with highest alkyl substituents (C10, C12, C14, C16, C18) on the permeability of cell membranes for sodium ions in vitro. Methods. In vitro studied was the effect of different concentrations of new quaternary phosphonium salts with highest alkyl substituents on the cell membrane permeability to sodium ions according to the rate of Na+-Li+-countertransport in the erythrocyte membrane. Results. Low concentration (0.001 mM) of substance C10 increased the rate of Na+-Li+-countertransport in the erythrocyte membrane by 11.9%, substance C12 - by 11.8%, substance C14 - by 12.7%, substance C16 - by 13%, substance C18 - by 12.3%. Higher concentrations of substances (0.01-0.05 mM) had no significant effect on the cell membrane permeability to sodium ions. Conclusion. An increase in the rate of Na+-Li+-countertransport in the erythrocyte membrane is influenced by minimal concentrations of a substance, under the influence of other concentrations the rate of Na+-Li+-countertransport doe not change.

About the authors

O V Orlova

Kazan State Medical University, Kazan, Russia

Email: olqa570821@yandex.ru

V N Oslopov

Kazan State Medical University, Kazan, Russia

S A Sidullina

Kazan State Medical University, Kazan, Russia

References

  1. Агафонов А.А., Пиотровский В.К. Программа M-IND-оценки системных параметров фармакокинетики модельно-независимым методом статистических моментов // Хим.-фарм. ж. - 1991. - №10. - С. 16-19.
  2. Березовская И.В., Иванова В.М. Актуальные проблемы безопасности воспроизведённых лекарственных препаратов // Клин. исслед. лекарств. средств в России. - 2004. - №3-4. - С. 16-23.
  3. Егорова С.Н. Методы моделирования in vitro чрескожного всасывания лекарственных средств из лекарственных форм местного действия // Казан. мед. ж. - 2000. - №2. - С. 146-147.
  4. Постнов Ю.В., Орлов С.Н. Первичная гипертензия как патология клеточных мембран. - М.: Медицина, 1987. - 192 с.
  5. Bressole F., Bromet-Petit M., Audran M. Validation of liquid chromatographic and gas chromatographic methods. Applications to pharmacokinetics // J. Chromatogr. B. - 1996. - Vol. 686. - P. 3-10.
  6. Canessa M., Adragna N., Solomon H. et al. Increased sodium-lithium countertransport in red cells of patients with essential hypertension // New Engl. J. Med. - 1980. - Vol. 302. - P. 772-776.
  7. Karifes H.T., Shiu G., Shah V.P. Validation of bioanalytical methods // Pharmaceut. Research. - 1991. - Vol. 8. - P. 421-425.
  8. Shah V.P., Midha K.K., Shrihant D. et al. Analitical metods validation: bioavailability, bioequivalence and pharmacokinetic stadies. Conference report // Pharmaceut. Research. - 1992. - Vol. 9. - P. 588-592.
  9. Turck D., Busch U., Heinzel G., Narjes H. Clinical Pharmacokinetics of Meloxicam // Arzneim. Forsch. - 1997. - Vol. 3. - P. 253-258.

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2012 Orlova O.V., Oslopov V.N., Sidullina S.A.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).